Published in Pain and Central Nervous System Week, July 17th, 2006
"Model systems have shown that adenoviral vector-mediated transient gene expression can potentially be applied for the treatment of brain tumors, neurodegenerative diseases, and brain injuries. Most studies utilized adenovirus serotype 5 (Ad5) based vectors, which as adhesion molecules require the coxsackie adenovirus receptor (CAR) as a critical determinant for cellular infection. In this report, we have systematically characterized CAR expression in the adult human central nervous system (CNS) by using immunohistochemistry," researchers in Sweden...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pain and Central Nervous System Week